Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase EARLY_PHASE1 1

Status

Active not recruiting 3Recruiting 2Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 3NIH 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 88Gynecologic 29Breast 18Head & Neck 14Gastrointestinal 13Genitourinary 7CNS 7Other solid neoplasm 6Dermatologic 4Tumor-Agnostic 3Sarcoma 3Lymphoid 3Endocrine 2

Conditions

Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Urothelial Cancer 1Muscle Invasive Bladder Urothelial Carcinoma 1Carcinoma, Transitional Cell 1

Interventions

Magnetic Resonance Spectroscopy 44Specimen Handling 38enzalutamide 30Nivolumab 30pembrolizumab 28Docetaxel 23Gemcitabine 22apalutamide 20Prednisone 20Biopsy 20Abiraterone Acetate 18Androgen Antagonists 17cabozantinib 14darolutamide 13abiraterone 13Radiotherapy 13Cisplatin 12enfortumab vedotin 11Radiation 11Ipilimumab 11Pluvicto 10erdafitinib 9belzutifan 9atezolizumab 9X-Rays 9Radiosurgery 9Mitomycin 9olaparib 8cabazitaxel 8Standard of Care 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Carboplatin × Genitourinary × 30 days × Clear all
NCT06524544 2026-06-02

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
320 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT06632977 2026-06-02

PREDICT

Alliance for Clinical Trials in Oncology

Phase 2 Recruiting
474 enrolled
Genitourinary

Prostatic Neoplasms

NCT04223856 2026-05-29

EV-302

Astellas Pharma Inc

Phase 3 Active not recruiting
886 enrolled 12 charts 1 FDA
Genitourinary

Urothelial Cancer

NCT03682068 2026-05-28

NILE

AstraZeneca

Phase 3 Active not recruiting
1,246 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06225596 2026-05-27

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

BicycleTx Limited

Phase 2 Active not recruiting
375 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03934840 2026-05-26

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡